ask="5.65"
ask_size="600"
average_daily_volume="518185"
bid="2.53"
bid_size="2000"
book_value="2.30"
change="-0.08"
change_from_200_day_moving_average="-0.63"
change_from_50_day_moving_average="-0.19"
change_from_52_week_high="-2.66"
change_From_52_week_low="1.04"
change_in_percent="-1.90%"
close="4.14"
dividend_pay_date="12/30/2013"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.68"
ebitda="-43.09M"
eps_estimate_current_year="-1.47"
eps_estimate_next_quarter="-0.25"
eps_estimate_next_year="-0.84"
ex_dividend_date="12/31/2013"
float_shares="39812000"
high="4.24"
high_52_weeks="6.80"
last_trade_date="2/24/2017"
last_trade_price="4.14"
last_trade_size="3811"
last_trade_time="4:00pm"
low="4.10"
low_52_weeks="3.10"
market_capitalization="270.87M"
moving_average_200_day="4.77"
moving_average_50_day="4.33"
name="Aralez Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="8.75"
open="4.17"
pe_ratio="N/A"
peg_ratio="-0.10"
percent_change_from_200_day_moving_average="-13.16%"
percent_change_from_50_day_moving_average="-4.45%"
percent_change_from_52_week_high="-39.12%"
percent_change_from_52_week_low="+33.55%"
previous_close="4.22"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.83"
price_per_sales="6.86"
revenue="40.23M"
shares_outstanding="65427000"
short_ratio="8.92"
stock_exchange="NMS"
symbol="ARLZ"
volume="355805"
weeks_range_52="3.10 - 6.80"
